OverviewSuggest Edit

Lipocine is a specialty pharmaceutical company developing pharmaceutical products using its oral drug delivery technology in the areas of men's and women's health. The Company offers a portfolio of proprietary product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate is LPCN 1021, an oral testosterone replacement therapy.

TypePublic
Founded1997
HQSalt Lake City, UT, US
Websitelipocine.com

Latest Updates

Employees (est.) (Dec 2019)12(+20%)
Revenue (FY, 2019)$165 K(-61%)
Share Price (Jan 2021)$1.8 (+9%)
Cybersecurity ratingAMore

Key People/Management at Lipocine

Mahesh V. Patel

Mahesh V. Patel

Chairman, President and Chief Executive Officer
Morgan Brown

Morgan Brown

Executive Vice President and Chief Financial Officer
Greg Bass

Greg Bass

Executive Vice President and Chief Commercial Officer
Jyrki Mattila

Jyrki Mattila

Executive Vice President and Chief Business Officer
Anthony DelConte

Anthony DelConte

Chief Medical Director
Show more

Lipocine Office Locations

Lipocine has offices in Salt Lake City and Trenton
Salt Lake City, UT, US (HQ)
675 Arapeen Dr #202
Trenton, NJ, US
3150 Brunswick Pike #130
Show all (2)

Lipocine Financials and Metrics

Lipocine Revenue

Lipocine's revenue was reported to be $164.99 k in FY, 2019
USD

Net income (Q2, 2020)

(6.4m)

EBIT (Q2, 2020)

(4.2m)

Market capitalization (19-Jan-2021)

115.6m

Closing stock price (19-Jan-2021)

1.8

Cash (30-Jun-2020)

13.8m

EV

108.1m
Lipocine's current market capitalization is $115.6 m.
Annual
USDFY, 2012Y, 2013FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

428.0k165.0k

General and administrative expense

76.7k3.6m5.0m5.8m10.4m10.2m5.3m5.6m

R&D expense

5.1m15.5m12.6m8.1m11.0m6.5m7.5m

Operating expense total

76.7k8.8m20.6m18.6m19.2m21.2m11.8m13.1m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

428.0k165.0k

General and administrative expense

2.2k3.3k5.7k3.2k6.3k1.2m1.9m1.0m871.8k1.1m1.1m1.7m4.4m3.2m1.4m1.8m2.0m2.7m1.7m1.7m930.1k1.2m1.4m1.4m2.1m2.0m

R&D expense

1.6m3.4m6.0m3.2m1.9m3.2m4.7m2.7m2.6m1.5m3.1m4.1m2.0m1.4m1.5m1.4m1.9m2.0m1.7m2.5m2.3m

Operating expense total

2.2k3.3k5.7k3.2k6.3k2.8m5.3m7.0m4.1m3.0m4.3m6.5m7.1m5.9m3.3m5.0m6.2m4.8m3.1m3.2m2.4m3.1m3.4m3.1m4.6m4.2m
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

577.045.3m27.7m20.0m5.6m3.2m8.1m9.7m

Accounts Receivable

Prepaid Expenses

770.0k229.9k350.2k408.2k520.1k545.9k

Inventories

Show all financial metrics

Lipocine Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Lipocine Online and Social Media Presence

Embed Graph

Lipocine News and Updates

Lipocine Announces Tentative Approval of TLANDO™

SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration ("FDA") has granted tentative approval to TLANDO, its oral...

Lipocine Announces Deletion of Unauthorized Changes to Company's Website

SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that an independent contractor posted on Lipocine's website (www.lipocine.com), without authorization from...

Lipocine Provides New Regulatory Update on TLANDO™

SALT LAKE CITY, Dec. 4, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration ("FDA") has informed the Company that it is continuing to work...

Thinking about buying stock in Wave Life Sciences, Axovant Gene Therapies, Lipocine Inc, Workhorse Group, or Cassava Sciences?

NEW YORK, Sept. 21, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WVE, AXGT, LPCN, WKHS, and SAVA. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in UnitedHealth, VBI Vaccines Inc, ADMA Biologics, Qutoutiao, or Lipocine Inc?

NEW YORK, Aug. 28, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for UNH, VBIV, ADMA, QTT, and LPCN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Northern Dynasty Minerals, Fluent Inc, Lipocine Inc, NetApp Inc., or HP?

NEW YORK, Aug. 27, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NAK, FLNT, LPCN, NTAP, and HPQ. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
Show more

Lipocine Frequently Asked Questions

  • When was Lipocine founded?

    Lipocine was founded in 1997.

  • Who are Lipocine key executives?

    Lipocine's key executives are Mahesh V. Patel, Morgan Brown and Greg Bass.

  • How many employees does Lipocine have?

    Lipocine has 12 employees.

  • What is Lipocine revenue?

    Latest Lipocine annual revenue is $165 k.

  • What is Lipocine revenue per employee?

    Latest Lipocine revenue per employee is $13.7 k.

  • Who are Lipocine competitors?

    Competitors of Lipocine include Rapafusyn Pharmaceuticals, Evrys Bio and Pherecydes Pharma.

  • Where is Lipocine headquarters?

    Lipocine headquarters is located at 675 Arapeen Dr #202, Salt Lake City.

  • Where are Lipocine offices?

    Lipocine has offices in Salt Lake City and Trenton.

  • How many offices does Lipocine have?

    Lipocine has 2 offices.